Determination of donepezil hydrochloride in human plasma and pharmaceutical formulations by HPLC with fluorescence detection

Acta Pharmaceutica

Volumn 61, Issue 4, 2011, Pages 403-413

  Abonassif, Mohammed A ^a   Hefnawy, Mohammed M ^a   Kassem, Mohamed G ^a   Mostafa, Gamal A E ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

donepezil hydrochloride; dosage form; fluorescence detection; plasma; RP HPLC

Indexed keywords

BUFFER; DONEPEZIL; METHANOL; PHOSPHATE; PINDOLOL; TRIETHYLAMINE;

ACCURACY; ARTICLE; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SELECTIVITY; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; LIQUID LIQUID EXTRACTION; MICELLAR LIQUID CHROMATOGRAPHY; QUALITY CONTROL; ROOM TEMPERATURE; SENSITIVITY ANALYSIS; STANDARD; TABLET;

EID: 84855216375     PISSN: 13300075     EISSN: 18469558     Source Type: Journal    
DOI: 10.2478/V10007-011-0035-1     Document Type: Article

References (19)

1. H. Sugimoto, Y. Tsuchiya, H. Sungmi, K. Higurahi, N. Karibe, Y. Iimur, A. Sasaki, Y. Kawakami, T. Nakamura, S. Araki, Y. Yamanishi and K. Yamatssu, Novel piperidine derivatives. Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[2-(N-benzoylamino)ethyl]piperidine derivatives, J. Med. Chem. 33 (1990) 1880-1887 (Pubitemid 20228971)
2. I. T. Lott, K. Osann, E. Dorn and L. Nelson, Down syndrome and Alzheimer disease: Response to donepezil, Arch. Neurol. 59 (2002) 1133-1136 (Pubitemid 34755826)
3. S. Kafkala, S. Matthaiou, P. Alexaki, M. Abatzis, A. Bartzeliotis and M. Katsiabani, New gradient high-performance liquid chromatography method for determination of donepezil hydrochloride assay and impurities content in oral pharmaceutical formulation, J. Chromatogr. A 1189 (2008) 392-397; DOI: 10.1016/j.chroma.2007.12.015
4. H. Pappa, R. Farrú, P. O. Vilanova, M. Palacios and M. T. Pizzorno, A new HPLC method to determine donepezil hydrochloride in tablets, J. Pharm. Biomed. Anal. 27 (2002) 177-182 (Pubitemid 33001394)
5. B. S. Sultry, S. Gananadhamu, D. Devadasu and K. Balaji, New RP-HPLC method for estimation of donepezil hydrochloride in pharmaceutical formulations, Int. J. Chem. Sci. 6 (2008) 1976-1983
6. N. Y. Furukori, R. Furuya, T. Takahata and T. Tateishi, Determination of donepezil, an acetylcholinesterase inhibitor, in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection, J. Chromatogr. B 768 (2002) 261-265 (Pubitemid 34158861)
7. M. A. Radwan, H. H. Abdine, B. T. Al-Quadeb, H. Y. Aboul-Enien and K. Nakashima, Stereoselective HPLC assay of donepezil enantiomers with UV detection and its application to pharmacokinetic in rats, J. Chromatogr. B. 830 (2006) 114-119; DOI: 10.1016/j.jchromb.2005.10.031 (Pubitemid 41831396)
8. J. S. Hiten, L. K. Mohan, P. Ankit, P. Shivkumar, S. Gunta, P. N. Chhagan, M. P. Dasharath and N. S. Bhanu, A rapid and specific approach for direct measurement of donepezil concentration in human plasma by LC-MS/MS employing solid-phase extraction, Biomed. Chromatogr. 23 (2009) 141-151, DOI: 10.1002/bmc.1095
9. P. E. Jeong, L. H. Won, J. H. Young, K. H. Yoon, L. M. Hyung, P. Eun-Seok, L. K. Choon and L. H. Suk, Hydrophilic interaction chromatography-tandem mass spectrometry of donepezil in human plasma: Application to a pharmacokinetic study of donepezil in volunteers, Arch. Pharm. Res. 31(2008) 1205-1211
10. Y. Hsin-Hua, Y. Yuan-Han, K. Ju-Yun and C. Su-Hwei, Sensitive analysis of donepezil in plasma by capillary electrophoresis combining on-column field-amplified sample stacking and its application of Alzheimer's disease, Electrophoresis 29 (2008) 3649-3657; DOI: 10.1002/elps.200800276
11. K. Nakashima, K. Itoh, M. Kono, M. N. Nakashima and M. Wada, Determination of donepezil hydrochloride in human and rat plasma, blood and brain microdialysates by HPLC with a short C30 column, J. Pharm. Biomed. Anal. 41 (2006) 201-206; DOI: 10.1016/j.jpba.2005.10.017
12. G. M. Khaledi, Micelles as separation media in high-performance liquid chromatography and high-performance capillary electrophoresis: Overview and perspective, J. Chromatog. A 780 (1997) 3-40
13. V. Meyer, Practical High-Performance Liquid Chromatography, 3rd ed., Royal Society of Chemistry, London, 1998, pp. 14-16
14. FDA Guidance for Industry: Bioanaytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Rockville (MD) 2001
15. G. A. Shabir, Validation of high-performance liquid chromatography methods for pharmaceutical analysis, understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization, J. Chromatogr. A 987 (2003) 57-59; DOI: 10.1016/S0021-9673(02) 01536-4 (Pubitemid 36140080)
16. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1), Complementary Guideline on Methododology dated 06 November 1996, incorporated in November 2005, London
17. H. Ermer, Validation in pharmaceutical analysis. Part I. An integrated approach, J. Pharm. Biomed. Anal. 24 (2001) 755-767; DOI: 10.1016/S073-7085(00) 00530-6
18. J. N. Miller and J. C. Miller, Statistics and Chemometrics for Analytical Chemistry, 5th ed., Tottenham (UK), 2005
19. Donepezil hydrochloride tablets, USP Pending Monograph Guideline, Version 2, USP Convention, Rockville (MD) 2009, USA http://www.usp.org.